Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Linsitinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 4910.00 | 5810.50 | 0.8450 | 0.5738 |
| SK-BR-3 | Erlotinib | 19.9526 | uM | 9 | 5000.00 | 3570.27 | 2964.00 | 5810.50 | 0.5101 | -0.2327 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 4032.00 | 5810.50 | 0.6939 | 0.1890 |
| SK-BR-3 | Lapatinib | 0.0016596 | uM | 9 | 5000.00 | 3570.27 | 6068.00 | 5810.50 | 1.0443 | 1.1273 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5980.00 | 5810.50 | 1.0292 | 1.0835 | |
| SK-BR-3 | 17-AAG | 0.1 | uM | 9 | 5000.00 | 3570.27 | 3462.00 | 5810.50 | 0.5958 | -0.0429 |
| SK-BR-3 | Erlotinib | 0.1 | uM | 9 | 5000.00 | 3570.27 | 5871.00 | 5810.50 | 1.0104 | 1.0297 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 3358.00 | 5810.50 | 0.5779 | -0.0835 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 5960.00 | 5810.50 | 1.0257 | 1.0736 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 5000.00 | 3570.27 | 5270.00 | 5810.50 | 0.9070 | 0.7405 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 5745.00 | 5810.50 | 0.9887 | 0.9680 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 5000.00 | 3570.27 | 6057.00 | 5810.50 | 1.0424 | 1.1218 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 5000.00 | 3570.27 | 5905.00 | 5810.50 | 1.0163 | 1.0465 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 5000.00 | 3570.27 | 5999.00 | 5810.50 | 1.0324 | 1.0930 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 3115.00 | 5810.50 | 0.5361 | -0.1765 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 3076.00 | 5810.50 | 0.5294 | -0.1911 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5967.00 | 5810.50 | 1.0269 | 1.0771 | |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5556.00 | 5810.50 | 0.9562 | 0.8765 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 5000.00 | 3570.27 | 5181.00 | 5810.50 | 0.8917 | 0.6988 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 5000.00 | 3570.27 | 5682.00 | 5810.50 | 0.9779 | 0.9374 |
| SK-BR-3 | 0 | uM | 9 | 5000.00 | 3570.27 | 5756.00 | 5810.50 | 0.9906 | 0.9734 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 5000.00 | 3570.27 | 4170.00 | 5810.50 | 0.7177 | 0.2473 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 5000.00 | 3570.27 | 5977.00 | 5810.50 | 1.0287 | 1.0821 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 5000.00 | 3570.27 | 3719.00 | 5810.50 | 0.6401 | 0.0598 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 5000.00 | 3570.27 | 5336.00 | 5810.50 | 0.9183 | 0.7716 |